The use of antimuscarinics, phosphodiesterase type V inhibitors and phytotherapy for lower urinary tract symptoms in men

doi:10.1016/j.ajur.2017.05.002

Asian Journal of Urology, 2017, 4 (3): 191-194 doi: 10.1016/j.ajur.2017.05.002

Review

The use of antimuscarinics, phosphodiesterase type V inhibitors and phytotherapy for lower urinary tract symptoms in men

Kok Kit Ng, Foo Cheong Ng

Department of Urology, Changi General Hospital, Singapore

Abstract
Related Citation (15)

Download:

HTML

PDF (314KB)
Export: BibTeX | EndNote (RIS)

Abstract Besides the mainstay of α-blockers and 5α-reductase inhibitors, other forms of medical therapy complete the armamentarium in the treatment of lower urinary tract symptoms (LUTS) in men. These treatments can target specific symptoms as well as associated symptoms that would affect the quality of life of the patients. Many patients are bothered by storage symptoms, more so than the voiding symptoms. Antimuscarinics are efficacious and safe, provided the patients do not have high post void residual urine. Many patients with LUTS also have erectile dysfunction, and phosphodiesterase type V inhibitors are effective in relieving both LUTS as well as erectile dysfunction for such patients. Phytotherapy provides a popular and safe treatment for LUTS, however, the efficacy of the treatment has not been proven in well conducted prospective randomized controlled studies.

Key words： Benign prostatic hyperplasia Erectile dysfunction Lower urinary tract symptoms Muscarinic antagonists Phosphodiesterase 5 inhibitors Phytotherapy

Received: 06 September 2016 Published: 26 August 2017

Corresponding Authors: Kok Kit Ng,E-mail address:kok_kit_ng@cgh.com.sg. E-mail: kok_kit_ng@cgh.com.sg

	Service
	E-mail this article
	Add to citation manager
	E-mail Alert
	Articles by authors
	Kok Kit Ng
	Foo Cheong Ng

TRENDMD:

Cite this article:

Kok Kit Ng,Foo Cheong Ng. The use of antimuscarinics, phosphodiesterase type V inhibitors and phytotherapy for lower urinary tract symptoms in men[J]. Asian Journal of Urology, 2017, 4(3): 191-194.

URL:

http://www.ajurology.com/EN/10.1016/j.ajur.2017.05.002 OR http://www.ajurology.com/EN/Y2017/V4/I3/191